Audiologists in Oak Lawn, IL Accepting Medicare
8 Audiologists found. Showing 1 - 8
 Rachel Elizabeth Rurka, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 4440 W 95th St, Oak Lawn, IL 60453 Phone: 708-520-2891 |
Dr. Grace Haines-gallagher, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 4700 W 95th St Ste 104, Oak Lawn, IL 60453 Phone: 708-765-3277 |
Dr. Jane Osher, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 4440 W 95th St, Oak Lawn, IL 60453 Phone: 708-684-4693 Fax: 708-520-1985 |
Dr. Rachel Sarai Barr, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 4440 W 95th St Rm 1339h, Oak Lawn, IL 60453 Phone: 708-520-0515 |
Erin Holland, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 4440 W 95th St, Advocate Children's Hospital, Pediatric Rehabilitation, Oak Lawn, IL 60453 Phone: 708-684-8000 |
Kaley Babich, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 4928 W 95th St, Oak Lawn, IL 60453 Phone: 708-424-0143 |
 Avada Audiology & Hearing Care Audiologist Medicare: Not Enrolled in Medicare Practice Location: 4237 W 95th St, Oak Lawn, IL 60453 Phone: 708-636-7500 Fax: 708-636-7652 |
Laura Shahtaji Audiologist Medicare: Not Enrolled in Medicare Practice Location: 4928 W 95th St, Oak Lawn, IL 60453 Phone: 708-424-0143 Fax: 708-425-8833 |
News Archive
FDA approves Novartis' Exelon Patch to treat mild to moderate AD
The US Food and Drug Administration has approved a higher dose of Exelon Patch (rivastigmine transdermal system) for the treatment of people with mild to moderate Alzheimer's disease.
Combination therapy is more effective at preventing recurrence of bipolar disorder
A review of 39 randomized clinical trials by scientists from UCLA and their colleagues from other institutions has found that combining the use medication with psychoeducational therapy is more effective at preventing a recurrence of illness in people with bipolar disorder than medication alone.
Avedro receives Gold MDEA award for Vedera System
Avedro, Inc. announced today that the Vedera System for performing Keraflex has received the prestigious Gold level 2011 Medical Design Excellence Award.
Seaside Therapeutics commences STX209 Phase 2b study in autism spectrum disorders
Seaside Therapeutics, Inc. announced today the initiation of a randomized, double-blind, placebo-controlled Phase 2b study to evaluate the effects of STX209 (arbaclofen) on social impairment in children, adolescents and adults with autism spectrum disorders.
› Verified 1 days ago
Physical Therapists
Speech-Language Pathologists
Occupational Therapists
Optometrists
Chiropractors
Podiatrists
Audiologists